EPZ015666 was highly selective for PRMT5 against other protein methyltransferases; exhibited dose-dependent inhibition of SmD3 dimethylation in mantle cell lymphoma (MCL) cells; and inhibited MCL cell proliferation in vitro and MCL xenograft tumor growth in vivo [388]. The gene discussed is PRMT5; the disease is neoplasm.